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Loci mapping in the/-region of the mouse H-2 gene complex control a  polymorphic 
group  of membrane  alloantigens,  denoted  as  /-region  associated  (Ia)  antigens  (1). 
Initially, two distinct Ia loci were defined (map order Ia-1, la-3). Cross-overs on opposite 
sides  of each  marker  locus  define  discrete  segments  of chromosome,  designated  as 
subregions (I-A and I-C, respectively). 
Antisera  detecting  the  product  of either  the Ia-1  or Ia-3  locus  each  precipitate  a 
distinct Ia molecule (2, 3), which consists of two noncovalently associated glycopolypep- 
tides  of mol  wt  of approximately 35,000  daltons  (a-subunit)  and  28,000  daltons  (fl- 
subunit)  (4). The demonstration that both a- and ~-subunits from different haplotypes 
have distinct amino acid sequences suggests that both subunits are encoded by structural 
loci mapping in the/-region (5). It is not known whether anti-Ia sera are reactive with 
determinants on both or only one of the subunits. 
One approach to estimating the number ofla loci mapping in the/-region is 
dependent  on determining  the  molecular  association of different  Ia antigenic 
specificities with distinct Ia molecules. Sequential immunoprecipitation analy- 
ses  have  thus  far  revealed  that  many  of  the  defined  Ia  specificities  are 
associated with one or the other of two separate Ia molecules (3, 6). These data, 
taken together with serological analyses of several intra-I-region recombinant 
strains,  provide evidence for the existence of two Ia loci, i.e., Ia-1  and Ia-3  (2, 
3, 6). 
In this  report,  we present coprecipitation  analyses  performed with  various 
antisera  reactive  with  products  of  loci  mapping  in  either  the  I-A  or  I-C 
subregions.  The  data  will  show  that  only  a  single  molecule  controlled  by  a 
locus  mapping  in  the  I-A  subregion  may  be  identified.  A  study  of the  I-C 
subregion  will  demonstrate  that  there  exist two  additional  Ia molecules con- 
trolled  by  loci  mapping  between  the  I-J  and  S  regions.  These  observations 
indicate  the presence of at least three/-region  loci which encode Ia molecules 
detectable  by  immunoprecipitation.  Preliminary  reports  of these  data  have 
been previously presented  (6-8). 
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Materials and Methods 
Mice.  All strains of mice  used in  this study  were  maintained in our colonies  at Stanford 
University and  the  University  of Toronto.  The  haplotype  origin  of the H-2  regions  of these 
strains and additional strains used for antiserum production are presented in Table I. 
Antisera.  The antisera used in these studies and the respective H-2  regions or subregions 
immunized against are as follows: A.TH anti-A.TL (anti-/k, S k, Gk); (B10.A(4R) x  A.SW)F1 anti- 
B10 (anti-K  ~, l-Ab);  (B10  ×  HTI)F1 anti-B10.A(5R) (anti-l-J  ~, I-E  k, I-C  d, S d, Gd); B10.S(7R) anti- 
B10.HTT (anti-l-E  k, I-C  k, S k, Gk); (B10.T(6R)  ×  (B10.D2)F~ anti-B10.AQR (anti-l-A  k, I-B  ~, I-J  ~, l- 
Ek).  These antisera were raised by hyperimmunization of recipient mice with donor spleen and 
lymph node lymphocytes as previously described (9). 
Preparation  of  12~l-Labeled  Spleen  Cell  Lysates.  Spleen  cell  suspensions  were  made  in 
Dulbecco's phosphate buffered saline containing 5%  (vol/vol) fetal calf serum  (D-PBS-FCS) ~ by 
the flushing out of spleens and the passage of cells through a nylon mesh as previously reported 
(10).  After removal of the erythrocytes from suspensions by lysis with Tris-NH4C1 (0.01  M Tris, 
pH  7.4,  0.85%  NH~C1),  the  residual  lymphocytes  were  routinely  greater  than  90%  viable  as 
judged by trypan blue dye exclusion. They were washed twice and resuspended with D-PBS at 5 
×  107  cells/ml  and their membrane  associated  proteins  were  labeled with  ~2sI (New  England 
Nuclear,  Boston,  Mass.,  low pH iodine, carrier-free,  450  mCi/ml) by using the lactoperoxidase- 
catalyzed  radioiodination  technique  (11).  After  radioiodination,  the  cells  were  washed  three 
times with D-PBS, resuspended at 108 cells/ml in PBS (0.02 M phosphate buffer, pH 7.4, 0.15 M 
NaC1)  containing 0.5%  Non-idet  P-40  (NP-40,  Particle  Data  Systems,  Chicago,  Ill.)  and 3500 
Kallikrein Inactivator Units/ml of Trasylol (Sigma Chemical Co., St. Louis, Mo.), maintained for 
30 min at 4°C,  and the lysates then centrifuged for 1 h  at 100,000 g. 
Supernates from the above centrifugation were collected and either initially frozen at  -70°C 
or  immediately enriched for membrane glycoproteins by lentil lectin affinity chromatography 
(12).  The  latter  technique  was  applied  to  the  B10.A(5R)  but  not  B10  lysates.  Lentil  lectin, 
prepared  from brown kitchen lentiles  (Lens  culinaris),  was  a  kind gift from  Dr.  M.  Letarte, 
Department of Biological Research,  University of Toronto, Toronto,  Canada.  It was coupled to 
cyanogen-bromide-activated Sepharose 4B  (13)  at a  ratio of 6 mg lentil lectin/g Sepharose 4B. 
12SI-labeled  NP-40  lysates  were  fractionated  at  4°C  on  a  1  x  5-cm  lentil lectin column  in  the 
presence of PBS containing 0.3%  NP-40.  Approximately 5-10% of the total trichloroacetic acid 
precipitable radioactivity was recovered in the bound fraction, which was eluted with PBS-0.3% 
NP-40 containing 0.1 M  a-methyl-v-glucopyranoside (Sigma Chemical Co.).  Greater than 80% of 
immunoprecipitable Ia antigen activity was recovered in this fraction. 
Immunoprecipitation  and  Gel  Electrophoresis.  Lentil  lectin  column  bound  fractions  were 
precleared for radiolabeled Ig by treatment with goat anti-mouse IgG and normal mouse IgG as 
reported previously (10).  Portions of this precleared sample, taken to represent a  lysate derived 
from approximately 107 spleen lymphocytes, were treated with anti-Ia sera (10 /~l) for 30 min at 
4°C  and  goat  anti-mouse  IgG  (100  pl)  for  a  further  3-16  h  at  4°C.  Sequential  precipitation 
analyses were performed by using two anti-Ia sera by treatment of the supernate of a precipitate 
formed with one anti-la serum and goat anti-mouse IgG with a  second anti-In serum and goat 
anti-mouse IgG. Immunoprecipitates were washed three times with PBS-0.5% NP-40, dissolved, 
and  electrophoresed  under  reducing  conditions  on  0.6  x  10-cm  sodium  dodecyl  sulfate-12.5% 
polyacrylamide gels according to Laemmli (14),  as previously described (10).  The radioactivity in 
2-mm gel slices was quantitated with a  Searle gamma well counter (Searle Analytic Inc.,  Des 
Plaines, Ill.). The positions of migration of unlabeled marker mouse IgG heavy (H) and light (L) 
chains was  determined on either the same  or a  parallel gel by using Coomassie  Blue protein 
stain (14). 
Results 
The genetic organization of the/-region was examined by performing experi- 
ments designed to estimate  the number of Ia  genes present  in the known I- 
1  Abbreviations  used  in this paper:  D-PBS,  Dulbecco's phosphate buffered saline; PBS,  phos- 
phate buffered saline (0.02 M phosphate buffer, pH 7.4, 0.15 M NaC1); FCS, fetal calf serum; H, 
heavy; L, light; NP-40, Non-idet P-40. T.  L.  DELOVITCH,  D.  B.  MURPHY,  AND  H.  O.  McDEVITT 
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H-2 Haplotype Origin of Strains Used in This Study 
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Strain  Haplotype 
Region* 
I 
K  A  B  J  E  C  S  :  G  D 
B10/Sn  b  b  b  b  b  b  b  b  b  b 
B10.D2/Sn  d  d  d  d  d  d  d  d  d  d 
A.SW  s  s  s  s  s  s  s  s  s  s 
B10.A (4R)/Sg  h4  k  k  b  b  b  b  b  b  b 
HTI  i  b  b  b  b  b  b  b  ?  d 
B10.A (3R)/Sg  /3  b  b  b  b  k  d  d  d  d 
B10.A (5R)/Sg  /5  b  b  b  k  k  d  d  d  d 
A.TL/Sf  tl  s  h  k  k  k  k  k  k  d 
A.TH/Sf,  B10.S  (7R)/Sg  t2  s  s  s  s  s  s  s  s  d 
B10.HTT/Ph  t3  s  s  s  s  k  k  k  k  d 
B10.AQR (N4)/Klj  yl  q  k  k  k  k  d  d  d  d 
B10.T (6R)/Sg  y2  q  q  q  q  q  q  q  ?  d 
* Haplotype origin of regions according to references 2 and 17. 
subregions.  Coprecipitation  studies  were  conducted  by  treatment  of  B10, 
B10.A(5R), and B10.A(3R) radiolabeled spleen cell lysates with various anti-Ia 
sera. Samples were fractionated initially on a lentil lectin column to enrich for 
glycoprotein and to minimize nonspecific immunoprecipitation, and were then 
precleared for radiolabeled Ig. They were subsequently reacted with one anti- 
Ia  serum,  the  precipitate  was  discarded,  and the  supernate  further treated 
with  a  second  anti-Ia  serum.  The  latter  precipitate  was  analyzed  by  gel 
electrophoresis.  If treatment  with  the  first  antiserum  removes  all  antigen 
precipitable by the second antiserum, then the Ia specificities detected by both 
sera are considered to be present on the same molecule. Alternatively, if the 
second antiserum precipitates a residual peak of  radioactivity, then the specific- 
ities detected by the two antisera are considered to be present on separate Ia 
molecules. 
In all of the experiments to be described below, when lysates were reacted 
initially with a normal mouse serum and the supernate of that precipitate was 
then treated with an anti-Ia serum,  Ia peaks of activity in the 25,000-35,000 
mol wt region were always observed (results not shown). Similarly, under the 
conditions employed, each antiserum quantitatively removed from the lysates 
all its Ia reactivity in a  single precipitation. No Ia-like peaks were obtained 
when samples were first treated with a given anti-Ia serum, and the supernate 
of this precipitate was further reacted with the same anti-Ia serum (results not 
shown). 
Evidence  for  a  Single  Ia  Locus  in  the  I-A  Subregion.  The  molecular 
association of Ia specificities that map in the I-A  subregion was analyzed by 
using B10 lysates and antisera reactive both with H-2 determinants controlled 
by K b and Ia determinants controlled by I-A b.  The  antisera  employed were 1552  IMMUNOCHEMICAL  EVIDENCE  FOR  THREE la  LOCI 
H-2  REGION  SPECIFICITY 
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FIG.  1.  Coprecipitation of specificities  Ia.8 and Ia.9. B10 lysates were treated with either 
(B10.A(4R)  x  A.SW)F1 anti-B10  (A) or (B10.A(4R)  x  B10.D2)F1 anti-B10  (B).  Sequential 
precipitations  were performed in (C) and (D). The H-2 regions detected by the antisera are 
enclosed.  The H-2  and Ia specificities  detected on B10  target  cells  are listed.  Marker 
immunoglobulin H and L chains are indicated  by arrows. 
(B10.A(4R)  x  A.SW)F1  anti-B10  (anti-H-2.33,  anti-Ia.8,  Ia.20), 2 (B10.A(4R)  x 
B10.D2)F1  anti-B10(anti-H-2.33,  anti-Ia.9,  Ia.20), 2 and (B10.A(4R)  x  B10.HTT)F1 
anti-B10  (anti-H-2.33,  anti-Ia.8,  Ia.20). 2 As  shown in  Figs.  1 A  and  1 B,  three 
separate  molecules  were  precipitated  by  the  first  two  of the  above  antisera. 
These molecules correspond to proteins that have approximate mol wt of 45,000 
daltons  (H-2),  25,000-35,000  daltons  (Ia),  and  12,000  daltons  (presumably  fi-2- 
microglobulin), respectively.  A  similar result was obtained with the (B10.A(4R) 
x  B10.HTT)F~  anti-B10  antiserum  (T.  Delovitch,  unpublished  observations). 
Each of these antisera yielded two peaks of activity in the 25,000-35,000  mol wt 
region,  which  are  considered  to  represent  the  35,000  mol  wt  (a-subunit)  and 
28,000  (fi-subunit)  mol  wt  subunits  of Ia  antigens  (3-5).  It  should  be  noted, 
however,  that the electrophoretic  conditions used here have not permitted the 
optimum resolution of these  Ia subunits.  Reactivity  of B10  extracts  first with 
(B10.A(4R)  x  A.SW)F1  anti-B10  and second with (B10.A(4R)  x  B10.D2)F~  anti- 
B10  (Fig.  1 C), or in the reverse order (Fig.  1 D), resulted in the coprecipitation 
of the Ia antigens  detected.  A  similar observation was made when  (B10.A(4R) 
x  B10.HTT)F~  anti-B10  was  substituted  for  (B10.A(4R)  x  A.SW)F~  anti-B10 
(results  not shown).  These  data indicated  that specificities  Ia.8  and Ia.9,  both 
2 Specificities  detected by this antiserum are predicted from current Ia-specificity  charts (15). 
Although the pattern of cytotoxic reactivity of this antiserum with a standard panel of cells is 
consistent with this assignment, formal absorption analyses have not been performed. T.  L.  DELOVITCH,  D.  B.  MURPHY,  AND  H.  O.  McDEVITT  1553 
controlled  by  the  I-A  subregion,  are  present  on  either  two  separate  but 
structurally  homologous  molecules  or  the  same  molecule.  Similar  findings 
have  also been  recently  obtained  by other  investigators  (16).  Ia.20  has  also 
been found to be in association with the same molecule as Ia.8 and Ia.9 (15). It 
may be concluded, therefore,  that at least one Ia locus, Ia-1,  maps in the I-A 
subregion. 
Association  of Ia.15  with  an  I-A  Subregion  Molecule.  It  was  previously 
reported that the reactivity of an A.TH anti-A.TL serum with B10 target cells 
defined specificity Ia.3,  the only specificity purportedly determined by the I-B 
subregion  (1).  It was  thus  of considerable  interest  to  examine  whether  this 
specificity was present  on  a  molecule distinct  from that  specified by the I-A 
subregion (7).  However, it has been shown more recently that  an A.TH anti- 
A.TL serum detects a  second specificity, designated Ia.15  (6),  and that  strain 
B10 expresses this  specificity  (15).  Absorption  analysis  of the  activity of the 
A.TH  anti-A.TL  serum  used in this  study indicated that  it reacts  with Ia.15 
and not Ia.3  on B10 cells.  Strains  B10(H-2b), B10.D2(H-2d), and  B10.BR(H-2  k) 
clear antibody cytotoxic for B10 targets,  while strains  B10.M(H-2r),  B10.G(H- 
2q), and B10.s(H-2  s) fail to absorb this activity (D. Murphy, unpublished observa- 
tions). An Ia peak of activity was obtained in this combination (Fig. 2 A). The 
association of Ia. 15 with I-A subregion molecules was, therefore, examined. 
B10  lysates  were  treated  initially  with  A.TH  anti-A.TL  and  then  with 
(B10.A(4R)  ×  A.SW)F1  anti-B10.  These  antisera  reciprocally  removed the  Ia 
reactivity for each other (Figs. 2 C and 2 D). The (B10.A(4R)  x  B10.D2)F1 anti- 
B10 and (B10.A(4R) ×  B10.HTT)FI anti-B10 sera yielded identical results when 
each was tested in combination with the A.TH anti-A.TL serum (T. Delovitch, 
unpublished  observations).  These  observations  demonstrate  that  specificity 
Ia.15 is associated with a  molecule controlled by the Ia-1  locus, which maps in 
the/-A  subregion. 
Evidence  for  Two Ia Loci  Mapping  between  the I-J and  S  Regions.  The 
number  of Ia molecules controlled by the I-B---D  chromosomal  segment was 
also  investigated.  B10.A(5R)  lysates were treated  with  (B10  ×  HTI)F~  anti- 
B10.A(5R) (anti-/-J  k, I-E  k, I-C d, S d, G~?) and B10.S(7R) anti-B10.HTT(anti-I- 
E k,  I-C  k,  S k,  G k)  antisera.  Ia  molecules were  precipitated  by both  sera  (see 
Figs. 3 A and 3 B). Two main peaks of radioactivity corresponding in molecular 
size  to  the  a-  and  ~-subunits  of Ia  molecules  were  observed.  No  peaks  of 
radioactivity  were  precipitated  from  B10  extracts,  thereby  ruling  out  the 
presence  of autoantibody  and/or  antibody  crossreactive  with  I-A  subregion 
determinants.  When these experiments  were conceived,  it was assumed that 
both  antisera  potentially  contained  antibody  against  the  products  of  loci 
mapping  in  the  I-C,  S,  or  G  regions.  Since  no  Ia-like  molecule  has  been 
precipitated by an antiserum directed against determinants  controlled by loci 
mapping in the S  or G regions, it was initially deduced that the Ia polypeptides 
observed were controlled by the Ia-3 locus, which marks the I-C subregion (6). 
In view of the above deduction,  the independent  precipitation that occurred 
after treatment  of a  B10.A(5R) lysate first with B10.S(7R) anti-B10.HTT  and 
second with (B10 x  HTI)F1 anti-B10.A(5R) was an unexpected result (Fig. 3 C). 
Coprecipitation  occurred  in  the  reverse  direction  (Fig.  3 D).  This  pattern  of 
reactivity  demonstrated  the  association  of different  determinants  with  two 1554  IMMUNOCHEMICAL  EVIDENCE  FOR  THREE  Ia  LOCI 
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FIG.  2.  Association  of specificity Ia.15 with an I-A b subregion molecule. B10 lysates were 
treated with either A.TH anti-A.TL (A) or (B10.A(4R) x A.SW)F~ anti-B10 (B). Sequential 
precipitations were performed in (C) and (D). 
separate Ia molecules, i.e., one Ia molecule is detected by both antisera, while 
the second Ia molecule is detected only by the  (B10  ×  HTI)F]  anti-B10.A(5R) 
serum.  Thus,  these  data  suggested  the  localization of two Ia  loci  in the/-C 
subregion (6). 
Recently,  two additional Ia  loci, which map between the I-B  and S  regions, 
have been identified. The Ia-4  locus, which marks the I-J subregion,  controls 
determinants that are selectively expressed by suppressor T lymphocytes  (17). 
The immunochemical  nature of the Ia-4  product is unknown.  The Ia-5  locus, 
which  marks  the I-E  subregion  (intercalated  between I-J  and I-C),  controls 
determinants expressed by splenic and lymph node lymphocytes (2,  18). The Ia- 
5  product is a glycoprotein having a mol wt of 25,000-35,000  daltons. Since the 
(B10  ×  HTI)F1  anti-B10.A(5R)  serum used in the present analysis potentially 
contains  antibody  against  both  the Ia-4  and Ia-5  products,  further  analyses 
were  performed  to  determine  whether  either  of these  products  were  being 
detected. 
To  test  for the  involvement  of the Ia-4  product,  strain  B10.A(3R)  lysates 
were treated with the same two antisera used above (Fig. 4).  Strain B10.A(3R) 
and  strain  B10.A(5R)  differ only  in  the I-J  subregion,  i.e.  strain  B10.A(3R) 
carries  the Ia-4 b  allele,  while  strain  B10.A(5R)  carries  the Ia-4 k  allele  (17). 
Since  strains  B10  and  HTI  both  carry  the  I-J b  subregion  (17),  the  (B10  × 
HTI)F1  anti-B10.A(5R)  serum cannot detect Ia-4 b determinants.  Nevertheless, 
independent precipitation was again  observed with B10.A(3R)  lysates treated T.  L.  DELOVITCH,  D.  B.  MURPHY,  AND  H.  O.  McDEVITT 
POTENTIAL 
ANTISERUM  H-2 REGION  I SUBREGION 
IMMUNIZED  DETECTED ON  TARGET CELL 
AGAINST  B10.A (SRI*  =B10.AISR)  SPLEEN 
KABJ  ECSGD  H  L  A 
Recipi~t:  (BIlDxHTZ)F 1  b b b b b b b b b 
bbbbbbb?d 
Donor:  B10,A(SR)  b b bl~]d 
Recipient:B1O.HTT  B10.S(TR)  ........  ~  d  EkC  d  :~  ~  B 
1. B10.SI7R  )=mti-B  10.HTT  1.  E._kc  d 
2, (BIOxHTI)F  1  2.  lkE._k~_  i  anti-B10.A(SR) 
O 
1. (B10xHTI)F  1  t.  jkEk~l 
mlti-B10.A(SR) 
2. B  10.S(7R  )a~tti-B  1O.HTT  2.  E  kCd 
2~  4S 
FRACTION 
"Underscore_ indicates subregion detected based 
on cumulative data  presented in  this  manuscript. 
Underscore  __ indicates po~ible subregion detected. 
S~e text, 
FIG. 3.  Evidence for distinct Ia molecules determined by loci  mapping between the I-B 
and S regions. B10.A(5R) lysates were reacted with either (B10 x HTI)F~ anti-B10.A(5R) 
(A) or B10.S(7R) anti-B10.HTT (B). Sequential precipitations were performed in (C) and 
(D). The l-subregions potentially detected on B10.A(5R) target cells  are listed. 
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first  with  the  B10.S(7R)  anti-B10.HTT  serum  and  second  with  the  (B10  x 
HTI)F1  anti-B10.A(5R)  serum  (Fig.  4 C).  It may be concluded,  therefore, that 
the Ia-4 locus does not code for either of the two Ia molecules detected here. 
The Ia-5  product  was  initially  detected  by  the  reactivity  of a  (C3H.Q  x 
B10.D2)F1  anti-B10.AQR  serum with B10.A(5R)  target cells (2).  Treatment of 
B10.A(5R)  lysates  with  a  similar  antiserum,  (B10.T(6R)  x  B10.D2)F1  anti- 
B10.AQR,  resulted in the precipitation of an Ia molecule  (Fig.  5 B).  Pretreat- 
merit  of B10.A(5R)  lysates  with  this  antiserum  cleared  all  activity  for  the 
B10.S(7R)  anti-B10.HTT serum and vice versa (Figs. 5 C and 5 D). In addition, 
as  shown in  Fig.  6,  the  (B10.T(6R)  x  B10.D2)F~  anti-B10.AQR  serum,  when 
tested in combination with the  (B10  x  HTI)F1  anti-B10.A(5R)  serum, yielded 
similar results to those presented in Fig.  3.  Therefore, both the  (B10.T(6R)  x 
B10.D2)F~  anti-B10.AQR  and  B10.S(7R)  anti-B10.HTT  sera  contain  antibody 
reactive with the same Ia molecule determined by the Ia-5 locus. It should also 
be noted that while the BI0.S(7R)  anti-B10.HTT serum could possibly contain 
antibody against I-C  subregion determinants,  it does not precipitate Ia mole- 
cules controlled by this subregion. 
These data  substantiate  the  claim for the  presence of two Ia  loci mapping 
between the I-J  and S  regions.  Moreover,  they  indicate  that  one  of the  loci 1556  IMMUNOCHEMICAL  EVIDENCE  FOR  THREE  Ia  LOCI 
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FzG. 4.  Independent  precipitation of Ia molecules controlled by two la loci in the I-B--S 
chromosomal segment. B10.A(3R) lysates were reacted with either (B10 x  HTI)F1 anti- 
B10.A(SR) or B10.S(7R) anti-B10.HTr (B). Sequential precipitations were performed in 
(C) and (D). 
involved, Ia-5, maps in the I-E subregion. However, the data do not permit one 
to definitively map the second locus, most likely Ia-3, to a particular subregion. 
It could map in either the I-E or I-C subregion (see Discussion below). 
Discussion 
Coprecipitation  analyses  presented  in  this  report  show  that  different  Ia 
determinants  are  associated  with three  separate  molecules.  Although no at- 
tempt  has been  made  to optimally resolve  the  a-  and /3-subunits of these  Ia 
molecules, or to determine whether either both or only one subunit is detected 
by the Ia antisera, these data suggest that at least three distinct Ia loci control 
determinants detectable  by immunoprecipitation.  According to the current I- 
region map, the data are consistent with the detection of products of the Ia-1, 
Ia-5,  and Ia-3  loci.  These  loci mark  the I-A, I-E,  and I-C subregions, respec- 
tively. 
If the a- and fl-subunits of the products of each of the above three Ia loci are 
encoded by/-region  genes,  then there  exist  a  minimum  of six  structural Ia 
genes in this region. Coprecipitation of different Ia determinants controlled by 
a  particular/-subregion  may  be  predicted  if they are  present  on either the 
same molecule or on separate but structurally homologous molecules. Serologi- 
cal crossreactivity between I-A  and I-C  subregion products,  which suggests a T.  L.  DELOVITCH,  D.  B.  MURPHY,  AND  H.  O.  McDEVITT  1557 
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Fro.  5.  Detection of the Ia-5  locus product.  B10.A(5R)  lysates were reacted with either 
B10.S(7R)  anti-B10.HTT  (A)  or  (B10.T(6R)  x  B10.D2)F1  anti-B10.AQR  (B).  Sequential 
precipitations were performed in (C) and (D). 
possible  structural  homology  between  these  products,  has  been  previously 
reported (6, 19).  It is possible that a given I-subregion codes for more than one 
Ia a- and fl-chain, and that these subunits are structurally similar. Sequential 
precipitation studies may therefore underestimate the total number of detecta- 
ble Ia molecules and may not indicate the overall extent of genetic complexity 
of the/-region. 
We are presently unable to determine whether the two loci  (Ia-5  and Ia-3) 
mapping between the I-J and S  regions are localized in the same or different I- 
subregions.  Cross-over positions in strains B10.A(3R) and B10.HTT form the K 
end  boundary  of the  I-E  subregion,  while  the  cross-over  position  in  strain 
B10.A  forms the D  end boundary  (2).  By  contrast,  the  cross-over position in 
strain  B10.A  forms the K  end boundary  of the I-C  subregion,  while  strains 
BSVS and A.TFR5 form the D  end boundary (1).  The crossover in strain B10.A 
is therefore pivotal in postulating two subregions. 
There are two problems in localizing the cross-over position in strain B10.A 
between the Ia-5  and Ia-3  loci. First,  the key point in this assignment  is the 
assumption  that this  strain  carries the Ia-3 d  allele.  Previously,  David  et  al. 
(20)  demonstrated  that  strain  A.TL  (I-C  k)  failed  to  absorb  B10.A(4R)  anti- 
B10.A(2R) antibody reactive with B10.D2 or B10.A(2R)  (I-C d) target cells. The 
specificity which distinguished Ia-3 d from Ia-3 k was designated Ia.6.  However, 1558  IMMUNOCHEMICAL  EVIDENCE  FOR  THREE  Ia  LOCI 
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FIG.  6.  Independent precipitation ofIa-5 andIa-3 locus products.  B10.A(5R) lysates were 
reacted  with  either  (B10  x  HTI)FI  anti-B10.A(5R)  (A)  or  (B10.T(6R)  ×  B10.D2)F1  anti- 
B10.AQR(B).  Sequential  precipitations were performed in (C) and (D). 
these  and  other  investigators  have  been  unable  to  produce  additional  sera 
which contain  anti-Ia.6  activity.  (All  antibody present in the  (B10  x  HTI)F1 
anti-B10.A(5R)  serum used in this study was absorbed with B10.BR  lympho- 
cytes,  indicating  the  absence  of Ia.6  antibody).  It  has  therefore  not  been 
possible to confirm the assignment of the Ia-3 d allele to strain B10.A. 
Second, two dimensional gel electrophoretic analyses  in which radiolabeled 
polypeptides are  separated  based on their net charge and molecular size  (21) 
reveal unique spot patterns for products of loci mapping between the I-J and S 
regions of haplotypes H-2 d  and H-2 k  (T. Delovitch,  unpublished observations, 
and  Jones  et  al.  [22]).  The  pattern  observed  with H-2 a  is  identical  to  that 
observed with H-2k; this implies that all spots observed are of H-2 k origin. One 
of the  antisera  used in the two dimensional  gel analysis  was the subsequent 
bleed of the (B10  x  HTI)F1 anti-B10.A(5R)  serum used in this study.  The data 
are thus consistent with both loci examined in this study being of H-2 k origin, 
which  would  localize  both  loci  in  the  I-E  subregion.  Experiments  are  in 
progress to confirm this assignment. 
Summary 
Sequential  immunoprecipitation  analyses  of  Ia  antigens  were  performed 
with 125I-labeled B10, B10.A(3R),  and B10.A(5R) spleen cell lysates. The results 
suggest  the  presence  of one/-region  associated  (Ia)  locus  (Ia-1)  in  the  I-A T.  L.  DELOVITCH~ D.  R.  MURPHY,  AND  H.  O.  McDEVITT  1559 
subregion.  In addition,  they indicate that two Ia loci map between the I-J and 
S  regions.  One locus, Ia-5,  maps in the I-E subregion.  The second locus,  most 
likely Ia-3,  maps in either the I-E or I-C subregion.  Taken together,  the data 
demonstrate that at least three Ia loci in the/-region of the H-2  complex code 
for molecules detectable by immunoprecipitation. 
We thank Carol Ostrem and Judy Biggin for their  superb technical  assistance,  and Patricia 
Camden for  her cheerful  secretarial  assistance. 
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